NEXT-GENERATION HUMAN PROSTATE CANCER COCULTURES TO OPTIMIZE AUTOLOGOUS CHIMERIC ANTIGEN RECEPTOR T-CELL IMMUNOTHERAPY

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators